Insmed (INSM) Operating Expenses (2010 - 2026)

Insmed's Operating Expenses history runs 17 years deep, the most recent figure standing at $459.3 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 34.7% year-over-year to $459.3 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 44.76% YoY), while the FY2025 annual figure was $1.9 billion, up 49.22% from the prior year.
• Operating Expenses for Q1 2026 stood at $459.3 million, down from $583.6 million in the prior quarter.
• The five-year high for Operating Expenses was $583.6 million in Q4 2025, with the low at $142.9 million in Q1 2022.
• The 5-year median for Operating Expenses is $306.9 million (2024), against an average of $310.1 million.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 103.7% in 2023, then climbed 3.58% in 2024.
• Insmed's Operating Expenses stood at $210.8 million in 2022, then gained by 24.29% to $262.0 million in 2023, then gained by 27.82% to $334.9 million in 2024, then soared by 74.28% to $583.6 million in 2025, then dropped by 21.3% to $459.3 million in 2026.
• Business Quant data shows INSM's Operating Expenses at $459.3 million in Q1 2026, $583.6 million in Q4 2025, and $508.3 million in Q3 2025.